KEGG   DRUG: Galegenimab
Entry
D12379                      Drug                                   
Name
Galegenimab (USAN/INN)
Formula
C2066H3194N550O673S12
Exact mass
46860.9262
Mol weight
46889.55
Sequence
(Heavy chain)
EVQLVQSGAE VKKPGASVKV SCKASGYKFT DSEMHWVRQA PGQGLEWIGG VDPETEGAAY
NQKFKGRATI TRDTSTSTAY LELSSLRSED TAVYYCTRGY DYDYALDYWG QGTLVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCD
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRASSSVE FIHWYQQKPG KAPKPLISAT SNLASGVPSR
FSGSGSGTDF TLTISSLQPE DFATYYCQQW SSAPWTFGQG TKVEIKRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide bridge: H22-H96, H146-H202, H222-L213, L23-L87, L133-L193)
  Type
Peptide
Efficacy
Angiogenesis inhibitor, Anti-HtrA serine peptidase 1 antibody
  Type
Monoclonal antibody
Comment
Treatment of geographic atrophy
Target
HTRA1 [HSA:5654] [KO:K08784]
Brite
Target-based classification of drugs [BR:br08310]
 Peptidases and inhibitors
  Serine peptidases
   Chymotrypsin family
    HTRA1
     D12379  Galegenimab (USAN/INN)
Other DBs
CAS: 2403683-24-7
PubChem: 497620792
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system